Navigation Links
MHA to Release Findings of Independent Long Term Care Member Study
Date:3/12/2008

FLORHAM PARK, N.J., March 12 /PRNewswire/ -- Managed Health Care Associates, Inc. (MHA) announces the completion of its inaugural Independent Long Term Care Member Study, the results of which will be revealed at the 2008 MHA Business Summit, March 27-28, 2008 in Las Vegas, Nevada.

The report was compiled from an electronic member survey issued in 2007 and examined self-reported data for key operational elements of Independent Long Term Care pharmacies, including pharmacy size and capacity, staffing ratios, patient mix, occupancy rates, pharmaceutical budget, use of diverse technologies, and several other categories that are critical to running a Long Term Care Pharmacy.

An overview of study results, as well as details on survey methodology, will be delivered at the conference via open forum allowing time for audience Q&A.

"We believe this study is a first of its kind and should be of great interest to all in the Long Term Care Pharmacy industry," stated Michelle Templin, MHA's Regional Vice President of Long Term Care. "As the leading group purchasing and managed care contracting organization serving LTC pharmacies, MHA is uniquely positioned to gather the statistically significant responses required to carry out this survey. Members requested this type of data to compare themselves to their peer group and to recognize opportunities to improve efficiency. With MHA's commitment to help our members compete effectively, we are pleased to have received such a high response rate to our first survey and to provide our membership with this valuable study on their pharmacies and the industry as a whole. We intend to conduct this survey annually and thus be able to identify future changes occurring within Long Term Care pharmacy."

MHA Members attending the Business Summit will receive a complimentary copy of the Independent Long Term Care Member Study. All members not in attendance will be able to request a copy of the study directly through their National Account Manager. Non-members and other interested parties can obtain copies by contacting MHA's Marketing Department.

About MHA

Managed Health Care Associates, Inc. (MHA) is the largest Alternate Site GPO in the country servicing the Long Term Care, Home Infusion, Combo Pharmacy and Specialty Pharmacy industries. MHA is also the leading Long Term Care Pharmacy Network Manager with focus on serving the Medicare D patient population. MHA's success is driven by unparalleled member support, competitive contracts, and the ability to create sophisticated, customized, web tools and reports, designed to increase savings and promote profitability. Members utilize MHA services to assist in the purchasing of a complete line of pharmaceuticals, medical supplies, capital equipment, and nutritional food, as well as network access to the majority of the largest national and regional prescription drug plans managing the Medicare Part D drug benefit. MHA also offers a variety of other services including contract administration, marketing, and continuing education. For more information, visit http://www.mhainc.com.

For More Information Contact:

Angela Elsier

Director of Marketing

Managed Health Care Associates, Inc.

800-642-3020 X2870

aelsier@mhainc.com


'/>"/>
SOURCE Managed Health Care Associates, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hooper Holmes Announces Fourth Quarter Earnings Release Date and Conference Call Information
2. Herley Industries, Inc. Second Quarter Earnings Release and Conference Call Notice
3. Novavax Announces Release Date of 2007 Fourth Quarter, Full Year Financial Results and Investor Conference Call
4. Cardiogenesis Corporation Announces Rescheduled Fourth Quarter and Full Year 2007 Earnings Release
5. Perrigo Company to Market Over-the-Counter Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride Extended-Release Tablets
6. Spheris Sets Fourth Quarter 2007 Earnings Release and Conference Call Dates
7. Somanetics Corporation to Release First Quarter 2008 Financial Results and Host Conference Call March 18, 2008
8. Report on 547 New Medicines in Development for Neurological Disorders Released in San Antonio
9. Dana Foundation releases arts and cognition research
10. U.S. Pharmacopeia Releases New Edition of the Food Chemicals Codex
11. US Pharmacopeia releases new edition of the Food Chemicals Codex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 28, 2017 , ... Qualidigm , the mission-driven national ... a new, more expansive office space in order to accommodate its growing number ... office building in Wethersfield, Conn. located at 936 Silas Deane Highway and immediately ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... of corrosive ions found in power plant water and steam. , Chlorides and ... turbines and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions ...
(Date:3/28/2017)... ... 28, 2017 , ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics ... in the country to sit on the 2017 National Advisory Board for Allergan’s Facial ... Dr. Harper helped propel the clinic from a small start-up to number 78 in ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... Advanced Surgical, Inc. is thrilled to offer the recently FDA-approved Obalon Balloon System ... procedure adds to SkyLex Advanced Surgical’s already comprehensive list of weight-loss services. ...
(Date:3/28/2017)... ... 28, 2017 , ... With expansion and efficiency in mind, Patten Seed Company ... seed processing plant opened in Marshallville in 2006, and a bagging and shipping facility ... for transition of Patten Seed operations to the Middle Georgia location from their previous ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 2017  A new survey from the ... Competitive Bidding Program (CBP) significantly reduced beneficiary choice and ... of choice forces beneficiaries to switch to unfamiliar or ... AADE,s survey is the latest in ... pointing out the inherent problems with the CBP. Last ...
(Date:3/27/2017)... -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... an immunotherapy for the treatment of multiple cancers, obtained through ... at the upcoming American Association for Cancer Research (AACR) ... to be held on April 1-5, 2017. ... An abstract titled ...
(Date:3/27/2017)... March 27, 2017  BERG, a biopharmaceutical ... biological research approach, today announced that the ... discovery of new data using a cold-induced ... fat metabolism. Joslin Diabetes Center led the ... platform for analysis of samples.  The findings ...
Breaking Medicine Technology: